A strain of Weissella fusion 92-2 with high production of extracellular polysaccharide and its application
By developing the fusion of high-yield extracellular polysaccharides, Weissella 92-2, the problem of low yield of extracellular polysaccharides in lactic acid bacteria has been solved, and efficient and low-cost polysaccharide production and industrial application has been achieved, which has improved its in many fields. Application potential.
Patent Information
- Application Number
- CN202410150054.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-02-02
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2044-02-02
Smart Images

Figure CN117987312B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of microbial technology, and more specifically to a strain of fusion Weissella 92-2 with high extracellular polysaccharide production and application thereof. Background Art
[0002] Exopolysaccharides (EPS) are natural extracellular macromolecules produced by lactic acid bacteria during their growth and metabolism, including homopolysaccharides composed of a single monosaccharide and heteropolysaccharides composed of different monosaccharides. However, the production capacity of lactic acid bacteria exopolysaccharides is highly strain-specific, and different strains produce EPS with different structures, i.e., different oligosaccharide compositions, ratios, molecular weights, and application properties. Therefore, in-depth research on the structural characteristics and application properties of lactic acid bacteria exopolysaccharides has become one of the current research hotspots in the field of microbial technology, but the strains screened so far generally have the problem of low polysaccharide production.
[0003] Therefore, fully exploring the high-polysaccharide-producing strains and their application characteristics is of great value for expanding their applications in agriculture, food, medicine, cosmetics and other fields. Summary of the invention
[0004] In view of this, the present invention provides a fusion Weissella 92-2 with high extracellular polysaccharide production. The extracellular polysaccharide of the strain has a high molecular weight and low dispersion. It is composed of glucose, belongs to dextran, and has a high degree of linearization (α-1,6 glycosidic bonds are greater than 97%). The extracellular polysaccharide fermentation production time is short, the yield is high, the separation and extraction process is simple, and it is suitable for industrial production.
[0005] In order to achieve the above object, the present invention adopts the following technical solution:
[0006] A strain of Weissella confusa 92-2 with high production of exopolysaccharide, the deposit number of which is CGMCC NO.28273. It was deposited in the General Microbiology Center of China Microbiological Culture Collection Administration Committee on August 28, 2023, and the deposit address is Institute of Microbiology, Chinese Academy of Sciences, No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, and is classified and named Weissella confusa.
[0007] Weissella is a lactic acid bacteria, widely distributed in fermented foods such as sausage, kimchi, soy sauce, fermented black beans, etc., and has the effects of improving the quality of fermented food products or shortening the fermentation cycle. The present invention integrates Weissella with outstanding extracellular polysaccharide production, and has good viscosity, thickening, stability and other properties. Furthermore, it also has a probiotic effect that promotes health and has a good growth-promoting effect on Lactobacillus rhamnosus. Its combined use can effectively improve the efficacy of probiotics.
[0008] Another object of the present invention is to provide a microbial agent, comprising the above-mentioned fused Weissella 92-2.
[0009] Another object of the present invention is to provide the use of the above-mentioned fused Weissella 92-2 or the above-mentioned microbial agent in the production of extracellular polysaccharides, wherein the extracellular polysaccharides are composed of glucose and are dextran. The extracellular polysaccharides have a high molecular weight, are composed of glucose, are dextran, and have a high degree of linearization (α-1,6 glycosidic bonds are greater than 97%).
[0010] Another object of the present invention is to provide a method for producing exopolysaccharides using the above-mentioned fusion Weissella 92-2, comprising the following steps:
[0011] (1) Seed culture: inoculate the fusion Weissella 92-2 into MRS seed culture medium, and culture at 37° C. for 16-28 hours to obtain seed liquid;
[0012] (2) Fermentation production: The seed liquid is transferred to MRS sucrose fermentation medium, and the fermentation culture is carried out at 30° C. for 24 h to 48 h to obtain a fermentation liquid;
[0013] (3) Isolation and extraction of extracellular polysaccharides: The fermentation broth was diluted 1-4 times by volume, centrifuged, and the supernatant was concentrated to the original volume on a rotary evaporator. 1-3 times the volume of 95% ethanol was added and mixed evenly. The mixture was allowed to stand at 4°C for 12-24 h, and centrifuged to obtain a precipitate. The precipitate was washed twice with an appropriate amount of ethanol, dried at 60°C, and crushed to obtain extracellular polysaccharides.
[0014] Another object of the present invention is to provide the application of the above-mentioned extracellular polysaccharide in food, cosmetics and agricultural production.
[0015] Beneficial effects:
[0016] (1) The fusion Weissella 92-2 provided by the present invention has high exopolysaccharide yield, low total nitrogen content of the product, short production time, simple separation and extraction process, low production cost, and is suitable for industrial production;
[0017] (2) The fusion Weissella 92-2 strain provided by the present invention has good safety, no hemolytic activity, and clear antibiotic resistance characteristics. The extracellular polysaccharide produced by the strain can be directly used as a thickener and film-forming agent in agriculture, food, medicine, cosmetics and other fields, and has low requirements for the separation and purification process.
[0018] (3) The fused Weissella 92-2 extracellular polysaccharide provided by the present invention has a high molecular weight and low dispersity, good water solubility and film-forming properties, and has a good growth-promoting effect on Lactobacillus rhamnosus. Its combined use can effectively improve the efficacy of probiotics. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.
[0020] Figure 1 : Colony morphology (A) and Gram staining characteristics (B) of strain Weissella confusa 92-2;
[0021] Figure 2 : Phylogenetic tree of strain Weissella confusa 92-2;
[0022] Figure 3 :Hemolytic characteristics of strain Weissella confusa 92-2;
[0023] Figure 4 : Molecular weight distribution diagram (GPC) of the extracellular polysaccharide molecular characteristics of strain Weissella confusa 92-2;
[0024] Figure 5 :Infrared characteristics of the extracellular polysaccharide molecular characteristics of strain Weissella confusa 92-2;
[0025] Figure 6 :Analysis of monosaccharide composition of the extracellular polysaccharide molecular characteristics of strain Weissella confusa 92-2;
[0026] Figure 7 :Nuclear magnetic resonance analysis of the molecular characteristics of the extracellular polysaccharide of strain Weissella confusa 92-2;
[0027] Figure 8 :Carbon spectrum of molecular characteristics of extracellular polysaccharide of strain Weissella confusa 92-2;
[0028] Fig. 9 :Fermentation broth of strain Weissella confusa 92-2 (A); Appearance of the prepared extracellular polysaccharide (B);
[0029] Fig.10 :Exopolysaccharide film-forming property of strain Weissella confusa 92-2;
[0030] Fig.11:Exopolysaccharides from Weissella confusa 92-2 promote the growth of Lactobacillus rhamnosus LGG(A) and LRa05(B). DETAILED DESCRIPTION
[0031] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0032] In order to further understand the present invention, the present invention is described in detail below in conjunction with the examples, wherein unless otherwise specified, the reagents involved in the examples can be purchased through commercial channels, and the methods not mentioned are conventional experimental methods and will not be described one by one here.
[0033] The following examples further illustrate the present invention, but should not be construed as limiting the present invention.
[0034] Example 1 Isolation and Identification
[0035] (1) Strain isolation and purification:
[0036] Take 0.5 g of hand-fermented vegetables from Xi'an, Shaanxi, cut the sample into 0.3 × 0.3 cm small pieces with sterile scissors, add 10 ml of sterile physiological saline, vortex and oscillate for 3 min, and dilute to 10 -7 , absorb 10 -4 ~10 -7 100 μL of the dilution solution was spread on MRS-sucrose solid medium, and the culture dish was placed in a 30°C constant temperature incubator for overnight culture to observe whether it produced extracellular polysaccharides. The sugar-producing bacteria were spotted on MRS solid medium with 2% calcium carbonate and cultured at 37°C for 24 hours; colonies with calcium-dissolving circles were picked, and acid-producing strains were further purified by streaking on MRS solid medium; Gram staining was performed and observed under a microscope, and strains with Gram-positive staining and rod-shaped microscopic morphology were selected (see Appendix Figure 1 ); the strain was stored in 25% glycerol at -80°C for future use.
[0037] (2) Strain identification: The DNA of strain 92-2 was extracted using a bacterial genome extraction kit (TaKaRa MiniBE ST Bacterial Genomic DNA Extraction kit ver2.0), and PCR amplification was performed using bacterial 16S rDNA universal primers: upstream primer 27F: AGAGTTTGATCCTGGCTCAG, SEQ ID NO.2; downstream primer 1492R: GGTTACCTTGTTACGACTT, SEQ ID NO.3.
[0038] PCR amplification reaction system (50 μL): 5.0 μL 10× Taq enzyme buffer, 0.4 μmol / L primer, 4 μL 200 mmol / L dNTP, 40 ng DNA template, 1 U Taq enzyme (Ta KaRa), 34 μL ddH2O.
[0039] The PCR reaction was amplified according to the following procedure: 95°C pre-denaturation for 5 min; 95°C denaturation for 30 s, 55°C annealing for 1 min, 72°C extension for 1 min, 35 cycles; and finally 72°C extension for 5 min. The reaction was carried out on a Bio-Rad PCR instrument, and the 16S rDNA amplified fragment was detected by 1% agarose gel electrophoresis and sent to Shenzhen Huada Gene Technology Co., Ltd. for sequencing. The sequencing results were compared with the sequences in GenBank by Blast. The results showed that the 16SrDNA gene sequence of the strain of the present invention (as shown in SEQ ID NO.1) had the highest similarity with the gene sequence of Weissella confuse JCM 1093, which was 97%. The phylogenetic tree was constructed using MEGA-X software. Combined with the physiological and biochemical characteristics, the strain was finally identified as Weissella confusa (see Appendix Figure 2 ). The strain was deposited in the General Microbiology Center of China Microbiological Culture Collection Administration on August 28, 2023, with the deposit address being Institute of Microbiology, Chinese Academy of Sciences, No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, and was classified and named Weissella confusa, with the deposit number being CGMCC NO.28273.
[0040]
[0041] Example 2 Safety Verification
[0042] (1) Antibiotic resistance characteristics
[0043] The experiment was conducted on a 96-well plate, and the antibiotics were gradiently diluted to make the concentrations of the diluted antibiotics 1024μg / ml, 512μg / ml, 256μg / ml, 128μg / ml, 64μg / ml, 32μg / ml, 16μg / ml, 8μg / ml, 4μg / ml, and 2μg / ml. 40μl of gradient diluted antibiotic solution, 158μl of MRS liquid culture medium, and 2μl of 92-2 bacterial solution after two generations of activation were added to the wells respectively; the experiment set up a negative control (sterile water instead of bacterial solution) and a positive control (sterile water instead of antibiotics). After constant temperature culture at 37℃ for 24h, the OD was detected using an enzyme marker. 600 The absorbance values are shown in Table 1.
[0044] Table 1
[0045]
[0046] Note: Drug resistance refers to the breakpoint value (BoriesG2008; EFSA2012). R, resistant; S, sensitive.
[0047] The results showed that the strain 92-2 of the present invention was resistant to vancomycin, kanamycin and gentamicin, indicating that the strain can be used together with the above antibiotics; it is sensitive to carbenicillin sodium, tetracycline, erythromycin, clindamycin and chloramphenicol. The antibiotic resistance characteristics of strain 92-2 are clear.
[0048] (2) Hemolysis test
[0049] After activating strain 92-2 for two generations, use an inoculation loop to streak on a blood plate, incubate at 37°C for 48 hours, and observe whether there is a hemolytic zone. If there is no transparent zone, it has no β-hemolytic activity, that is, it has no effect on hemolysis or does not hemolyze. The commercial strain LGG is used as a negative control, and the Staphylococcus aureus strain with β-hemolytic activity is used as a positive control.
[0050] Staphylococcus aureus produces a transparent circle on the blood plate, which indicates that it has β-hemolytic activity; strains 92-2 and LGG have no transparent circle around their bodies, so strain 92-2 does not have β-hemolytic activity and is safe (see Appendix Figure 3 ).
[0051] Example 3 Fermentation to produce exopolysaccharides
[0052] (1) Activation of bacterial strains: Transfer the 4°C slant-stored strain Weissella confusa 92-2 to MRS medium and culture at 37°C for 20 h;
[0053] (2) Seed culture: Pick a loop of 92-2 strain on the solid culture medium in step (1) and inoculate it into a sterilized 250-mL Erlenmeyer flask containing 100 mL of MRS culture medium at 37° C. for 18 h to obtain a seed solution;
[0054] (3) Fermentation culture: The seed solution prepared in step (2) was inoculated at an inoculum amount of 1% to 5% (v / v) into a sterilized 5L Erlenmeyer flask containing 2L of fermentation medium (100 g / L sucrose MRS medium), the culture temperature was 30° C., and the culture was allowed to stand for 24 hours to obtain a fermentation liquid;
[0055] (4) Isolation and extraction of extracellular polysaccharides: The fermentation broth obtained in step (3) was diluted 4 times by volume with distilled water, and the diluted fermentation broth was centrifuged (4°C, 10,000 rpm, 15 min), and the supernatant was concentrated to the original volume on a rotary evaporator, and 2 times the volume of 95% ethanol was added and mixed evenly, and the mixture was allowed to stand at 4°C for 18 h, and centrifuged (4°C, 4000-6000 rpm, 7 min) to obtain a precipitate. The precipitate was washed twice with an appropriate amount of ethanol, dried at 60°C, and crushed to obtain extracellular polysaccharides.
[0056] The extracellular polysaccharide produced by the above process has an output of 40.15 g / L and a total nitrogen content of 0.47 g / kg. The extracellular polysaccharide has a molecular weight of 238258.1 KDa and a polydispersity coefficient of 2.609. It is composed of glucose and belongs to dextran. It contains 97.55% α-1,6 glycosidic bonds and 2.45% α-1,3 glycosidic bonds, and has a high degree of linearization (see Appendix Figures 4 to 9 ).
[0057] Example 4 Application performance of extracellular polysaccharide
[0058] The purpose of this example is to test the application performance of the sample prepared in Example 3.
[0059] (1) Film-forming properties
[0060] Weigh 1.0 g of the extracellular polysaccharide from Example 3, add 40 mL of deionized water, stir and dissolve at room temperature overnight to obtain a polysaccharide solution, centrifuge at 6000 rpm for 10 min, and separate the supernatant. Pipette 3-5 mL of the supernatant, add it to a culture dish with a diameter of 60 mm, shake it left and right to spread the liquid evenly, place the culture dish in a clean bench and sterilize it with ultraviolet irradiation for 30 minutes, then let it stand at room temperature for 2 days to air-dry, and obtain a transparent polysaccharide film. The results show that the extracellular polysaccharide of strain 92-2 has good water solubility and film-forming properties (see Appendix Fig.10 ).
[0061] (2) Promoting the growth of probiotics
[0062] MRS medium was used as the basal medium, 5 g / L extracellular polysaccharide (the sample obtained in Example 3) was used as an added carbon source as the experimental group, 5 g / L inulin (known to those skilled in the art as a commonly used prebiotic carbon source) was used as an added carbon source as the prebiotic reference group, and 5 g / L xanthan gum (known to those skilled in the art as a commonly used thickener in the fields of food, cosmetics, etc.) was used as the comparison group.
[0063] Lactobacillus rhamnosus GG (Bayer Infant drops, Germany) and Lactobacillus rhamnosus LRa05 (Weikang Probiotics Co., Ltd., Suzhou) glycerol tubes were placed at room temperature, and after thawing, they were inoculated into MRS culture medium at a 1% inoculation amount for two consecutive activations, and then cultured at 37°C to obtain probiotic seed liquid. Take 1 mL of seed liquid (concentration 2*10 8 CFU / mL) were inoculated into 100 ml of inulin-MRS medium, xanthan gum-MRS medium and 92-2 extracellular polysaccharide medium, and cultured at 37°C for 48 h. Samples were taken at 0 h, 6 h, 12 h, 18 h, 24 h, 30 h, 36 h, 42 h, and 48 h, and the biomass OD was measured. 600 .
[0064] The results showed that the effect of the extracellular polysaccharide of strain 92-2 on promoting the growth of Lactobacillus rhamnosus was similar to that of inulin and significantly better than that of xanthan gum (see Appendix Fig.11 ).
[0065] The various embodiments in this specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments. The same or similar parts between the various embodiments can be referenced to each other.
[0066] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.
Claims
1. A fusion strain of Weissella with high production of exopolysaccharides ( Weissella confusa ) 92-2, characterized in that, The deposit number of the fusion Weissella 92-2 is CGMCC NO.28273.
2. A microbial agent, characterized in that: Comprising the fused Weissella 92-2 as described in claim 1.
3. Use of the fused Weissella 92-2 according to claim 1 or the microbial agent according to claim 2 in the production of extracellular polysaccharides.
